11-108327682-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000051.4(ATM):āc.7013T>Cā(p.Leu2338Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.7013T>C | p.Leu2338Pro | missense_variant | 48/63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATM | ENST00000675843.1 | c.7013T>C | p.Leu2338Pro | missense_variant | 48/63 | NM_000051.4 | ENSP00000501606.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461738Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727184
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 22, 2022 | This missense variant replaces leucine with proline at codon 2338 of the ATM protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). This variant has been observed in an individual affected with breast cancer (Color Health internal data). This variant has also been reported in the compound heterozygous state with c.6056A>G (p.Tyr2019Cys) in an individual affected with classic ataxia-telangiectasia (PMID: 22649200). Cells derived from this individual and in vitro studies showed this variant results in no detectable kinase activity (PMID: 19431188, 22649200). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The p.L2338P variant (also known as c.7013T>C), located in coding exon 47 of the ATM gene, results from a T to C substitution at nucleotide position 7013. The leucine at codon 2338 is replaced by proline, an amino acid with similar properties. This alteration has been reported in two breast cancer patients in a UK study of 13,087 breast cancer cases and 5,488 controls (Decker B et al. J Med Genet, 2017 11;54:732-741). In addition, in an in vitro study leveraging an ATM-null lymphoblastoid cell line complemented with different ATM mutant cDNA vectors, this alteration showed loss of kinase activity (Barone G et al. Hum Mutat, 2009 Aug;30:1222-30). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Familial cancer of breast Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 03, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at